WHO ICTRP trial
An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients…
EUCTR2020-005214-18-LT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2020-005214-18-LT |
|---|---|
| Public title | An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients without Pneumonia |
| Scientific title | An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients without Pneumonia - An open-label randomized controlled study |
| Primary sponsor | Vilnius University Hospital Santaros klinikos |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Lithuania |
| Conditions | COVID-19 Patients without Pneumonia;Therapeutic area: Diseases [C] - Virus Diseases [C02] |
| Interventions | Product Name: Favipiravir Product Code: T-705 Pharmaceutical Form: Tablet |
| Registration date | Apr 11, 2020 |
| Target size | 75 |
| Secondary IDs | T705-COVID-GCRI-Protocol-B |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: